Benzimidazole-triazole hybrids as antimicrobial and antiviral agents: A systematic review
M Marinescu - Antibiotics, 2023 - mdpi.com
Bacterial infections have attracted the attention of researchers in recent decades, especially
due to the special problems they have faced, such as their increasing diversity and …
due to the special problems they have faced, such as their increasing diversity and …
Targeting the p53 signaling pathway in cancers: molecular mechanisms and clinical studies
J Shen, Q Wang, Y Mao, W Gao, S Duan - MedComm, 2023 - Wiley Online Library
Tumor suppressor p53 can transcriptionally activate downstream genes in response to
stress, and then regulate the cell cycle, DNA repair, metabolism, angiogenesis, apoptosis …
stress, and then regulate the cell cycle, DNA repair, metabolism, angiogenesis, apoptosis …
How does TCR-T cell therapy exhibit a superior anti-tumor efficacy
D Yang, Z Duan, P Yuan, C Ding, X Dai, G Chen… - Biochemical and …, 2023 - Elsevier
TCR-engineered T cells have achieved great progress in solid tumor therapy, some of which
have been applicated in clinical trials. Deep knowledge about the current progress of TCR-T …
have been applicated in clinical trials. Deep knowledge about the current progress of TCR-T …
A decade of USFDA-approved small molecules as anti-inflammatory agents: Recent trends and Commentaries on the “industrial” perspective
Inflammation is the human body's defence process against various pathogens, toxic
substances, irradiation, and physically injured cells that have been damaged. Inflammation …
substances, irradiation, and physically injured cells that have been damaged. Inflammation …
N-heterocyclic carbene catalyzed [2+ 3] annulation reaction for the synthesis of trifluoroethyl 3, 2′-spirooxindole γ-lactam
Y Pu, M Wang, W Tian, X Ge, D Zhu, C Wang, Y Zeng… - RSC …, 2024 - pubs.rsc.org
Asymmetric catalytic processes promoted by N-heterocyclic carbenes (NHCs) hold great
potential for the sustainable preparation of chiral molecules. However, catalyzing the …
potential for the sustainable preparation of chiral molecules. However, catalyzing the …
Case report: The stroma-rich variant of Castleman's disease of hyaline-vascular type with atypical stromal cell proliferation and malignant potential: An exceptional …
X Shi, M Liao, X Yin, Y Chen, C Huang, W Yin… - Frontiers in …, 2023 - frontiersin.org
The stroma-rich variant of Castleman disease of hyaline-vascular type (SR-HVCD) is
characterized by interfollicular proliferation of the fibroblastic, myofibroblastic, and/or …
characterized by interfollicular proliferation of the fibroblastic, myofibroblastic, and/or …
KLF11 promotes the proliferation of breast cancer cells by inhibiting p53-MDM2 signaling
ZH Hou, M Tao, J Dong, HM Qiu, F Li, XY Bai - Cellular Signalling, 2024 - Elsevier
Abnormal Krüppel-like factor 11 (KLF11) expression is frequently found in tumor tissues and
is associated with cancer prognosis, but its biological functions and corresponding …
is associated with cancer prognosis, but its biological functions and corresponding …
Targeting G-rich sequence to regulate the transcription of murine double minute (MDM) genes in triple-negative breast cancers
Y Feng, X Xuan, Y Hu, J Lu, Z Dong, Z Sun… - European Journal of …, 2024 - Elsevier
Abstract Murine double minute 2 (MDM2) and homologous protein murine double minute X
(MDMX) are p53 negative regulators that perform significant driving effects in tumorigenesis …
(MDMX) are p53 negative regulators that perform significant driving effects in tumorigenesis …
Green Stereoselective Synthesis and In Silico Anticancer Evaluation of Tetrahydro-β-carboline-Derived Spiro Heterocycles
M Mohan, SP Eldhose, A Sudheendranath… - …, 2023 - thieme-connect.com
A green stereoselective synthesis of spiroheterocycles incorporating a spirooxindole and a
1, 2, 3, 4-tetrahydro-β-carboline (THβC) are demonstrated here by the one-pot, three …
1, 2, 3, 4-tetrahydro-β-carboline (THβC) are demonstrated here by the one-pot, three …
[HTML][HTML] P53/MDM2 complex-based targeted strategies in colon adenocarcinoma
A Niotis, E Tsiambas, D Dimitroulis… - Acta Medica …, 2023 - ncbi.nlm.nih.gov
In the current molecular review, we describe the mechanisms of TP53/MDM2 deregulation
and their impact on the colon adenocarcinoma molecular substrate and phenotype. Among …
and their impact on the colon adenocarcinoma molecular substrate and phenotype. Among …